missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. R&D Systems™ Vandetanib

R&D Systems™ Vandetanib

Catalog No. 749750
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
749750 50 mg
749710 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. 749750 Supplier R&D Systems™ Supplier No. 7497/50

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

Description

A Tocris product, part of R&D Systems. Potent VEGFR-2 inhibitor, also inhibits EGFR and RET oncoproteins activity

Vandetanib is a potent VEGFR-2 inhibitor (IC50 = 0.04 μM), and inhibitor of EGFR (IC50 = 0.5 μM). Vandetanib potently inhibits (IC50 = 100 nM) RET oncoprotein activity in human thyroid cancer. Vandetanib displays anti-angiogenic properties in human nasopharyngeal carcinoma in mice model. Vandetanib is orally available and effective in vivo.

Specifications

Chemical Name or Material N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
CAS 443913-73-3
Quantity 50 mg
Product Line Tocris
Target VEGF Receptor Inhibitors
Molecular Formula C22H24BrFN4O2
Purity 0.98